ArticleJMA journal2024

Methotrexate, Hydrocortisone, Vincristine, Sobuzoxane, and Etoposide Is an Effective Option for Relapsed T-cell Prolymphocytic Leukemia with Loss of CD52 Expression after Retreatment with Alemtuzumab.

Shohei Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.